Sandbox Reserved 1487

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (17:26, 14 January 2019) (edit) (undo)
 
(One intermediate revision not shown.)
Line 1: Line 1:
{{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
{{Sandbox_Reserved_ESBS}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE -->
-
==Your Heading Here (maybe something like 'Structure')==
+
==Thymidine Kinase from Herpes simplex virus type I compexed with 5-bromothienyldeoxyuridine==
-
<StructureSection load='1ki4' size='340' side='right' caption='Thymidine kinase from Herpes simplex virus type I compexes with 5-bromothienyldeoxyuridine' scene=''>
+
<StructureSection load='1ki4' size='340' side='right' caption='Thymidine kinase from Herpes simplex virus type I compexed with 5-bromothienyldeoxyuridine' scene=''>
== Introduction ==
== Introduction ==
Line 11: Line 11:
This protein is a [https://en.wikipedia.org/wiki/Phosphotransferase phosphotransferase] enzyme that catalyses the reaction:
This protein is a [https://en.wikipedia.org/wiki/Phosphotransferase phosphotransferase] enzyme that catalyses the reaction:
-
Deoxythymidine + ATP --> Deoxythymidine monophosphate + ADP
+
[https://en.wikipedia.org/wiki/Thymidine Deoxythymidine] + [https://en.wikipedia.org/wiki/Adenosine_triphosphate ATP] --> Deoxythymidine monophosphate + [https://en.wikipedia.org/wiki/Adenosine_diphosphate ADP]
Line 27: Line 27:
Each chain is bound to 2 chemical ligands. One of them is the sulfate ion SO4 which is linked to Gly 59, Gly 61, Lys 62, The 63 and Arg 222.<ref>https://www.ebi.ac.uk/pdbe/entry/pdb/1ki4/bound/SO4#3A</ref> The second one is the 5-Bromothienyleoxyuridine (BTD) which is linked to more amino acid<ref>https://www.ebi.ac.uk/pdbe/entry/pdb/1ki4/bound/BTD</ref> as Trp 88, Gln 125, Tyr 172, Glu 225 and Tir 101<ref>https://www.rcsb.org/structure/1KI4</ref>.
Each chain is bound to 2 chemical ligands. One of them is the sulfate ion SO4 which is linked to Gly 59, Gly 61, Lys 62, The 63 and Arg 222.<ref>https://www.ebi.ac.uk/pdbe/entry/pdb/1ki4/bound/SO4#3A</ref> The second one is the 5-Bromothienyleoxyuridine (BTD) which is linked to more amino acid<ref>https://www.ebi.ac.uk/pdbe/entry/pdb/1ki4/bound/BTD</ref> as Trp 88, Gln 125, Tyr 172, Glu 225 and Tir 101<ref>https://www.rcsb.org/structure/1KI4</ref>.
-
The active site is at the level of C-terminus of the first β-sheet of the polypeptide. It is surrounded by the lateral chain of 4 α-helices. It contains the thymidine which is in depth in the active site of the enzyme. It interacts with the enzyme thanks to Van der Waals interactions and hydrogen bond. In the periphery of the enzyme and so of the active site there is the binding site of ATP. The sulfate ion is nearby.<ref>PMID:9715911</ref>
+
The active site is at the level of C-terminus of the first β-sheet of the polypeptide. It is surrounded by the lateral chain of 4 α-helices. It contains the thymidine which is in depth in the active site of the enzyme. It interacts with the enzyme thanks to [https://en.wikipedia.org/wiki/Van_der_Waals_force Van der Waals interactions] and hydrogen bond. In the periphery of the enzyme and so of the active site there is the binding site of ATP. The sulfate ion is nearby.<ref>PMID:9715911</ref>
Line 38: Line 38:
HSV1 is transmitted mainly by contact with mucous membranes because of the presence of viral particles in wounds, saliva… It can also be transmitted to the genital sphere during oral sex, which causes genital herpes. In rare cases, the mother can transmit the virus to the new-born during the childbirth. In immunocompromised people, symptoms may be more severe and more frequent.
HSV1 is transmitted mainly by contact with mucous membranes because of the presence of viral particles in wounds, saliva… It can also be transmitted to the genital sphere during oral sex, which causes genital herpes. In rare cases, the mother can transmit the virus to the new-born during the childbirth. In immunocompromised people, symptoms may be more severe and more frequent.
-
After the first infection, wounds can reappear, and the frequency depends on person. Antivirals are used to reduce the viral load of people infected but they do not cure the infection. However, a mutation in the HSV1-TK protein causes the resistance of the virus against antivirals in immunocompromised patients. <ref>https://www.who.int/fr/news-room/fact-sheets/detail/herpes-simplex-virus</ref>
+
After the first infection, wounds can reappear, and the frequency depends on person. Antivirals are used to reduce the viral load of people infected but they do not cure the infection. However, a mutation in the HSV1-TK protein causes the resistance of the virus against antivirals in [https://en.wikipedia.org/wiki/Immunodeficiency immunocompromised] patients. <ref>https://www.who.int/fr/news-room/fact-sheets/detail/herpes-simplex-virus</ref>
== Therapeutic application ==
== Therapeutic application ==
-
The first suicide gene system developed for a therapeutic gene use, uses the thymidine kinase from Herpes simplex type I virus.
+
The first [https://en.wikipedia.org/wiki/Suicide_gene suicide gene] system developed for a therapeutic gene use, uses the thymidine kinase from Herpes simplex type I virus.
The aim was to develop a gene encoding an enzyme that performs an activity normally absent in the target cells of the therapy. This enzyme would then allow the synthesis of toxic compounds.
The aim was to develop a gene encoding an enzyme that performs an activity normally absent in the target cells of the therapy. This enzyme would then allow the synthesis of toxic compounds.
-
Aciclovir (ACV) and Ganciclovir (GVC) are 2 nucleosides analogues of guanosine. These are metabolized by HSV1-TK to a monophosphoryl compound which is then transformed into di and tri phosphate metabolites by cellular kinases. Then, ACV-TP and GVC-TP are incorporated into DNA during the elongation causing the death of infected cells by apoptosis. They also inhibit the viral replication. Death of cells is also triggered when they are treated with GVC when there has been an upstream transfection of the HSV1-TK gene outside a viral infection. <ref>http://www.ipubli.inserm.fr/bitstream/handle/10608/1401/1999_5_625.pdf?sequence=4</ref>
+
[https://en.wikipedia.org/wiki/Aciclovir Aciclovir](ACV) and [https://en.wikipedia.org/wiki/Ganciclovir Ganciclovir] (GVC) are 2 nucleosides analogues of [https://en.wikipedia.org/wiki/Guanosine guanosine]. These are metabolized by HSV1-TK to a monophosphoryl compound which is then transformed into di and tri phosphate metabolites by cellular kinases. Then, ACV-TP and GVC-TP are incorporated into DNA during the elongation causing the death of infected cells by [https://en.wikipedia.org/wiki/Apoptosis apoptosis]. They also inhibit the viral replication. Death of cells is also triggered when they are treated with GVC when there has been an upstream [https://en.wikipedia.org/wiki/Transfection transfection] of the HSV1-TK gene outside a viral infection. <ref>http://www.ipubli.inserm.fr/bitstream/handle/10608/1401/1999_5_625.pdf?sequence=4</ref>

Current revision

This Sandbox is Reserved from 06/12/2018, through 30/06/2019 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1480 through Sandbox Reserved 1543.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Thymidine Kinase from Herpes simplex virus type I compexed with 5-bromothienyldeoxyuridine

Thymidine kinase from Herpes simplex virus type I compexed with 5-bromothienyldeoxyuridine

Drag the structure with the mouse to rotate

References

  1. https://tel.archives-ouvertes.fr/tel-00720223/document
  2. https://www.uniprot.org/uniprot/P03176
  3. https://www.rcsb.org/structure/1KI4
  4. https://www.rcsb.org/pdb/explore/remediatedSequence.do?structureId=1KI4&params.chainEntityStrategyStr=all&forcePageForChain=A&params.annotationsStr=SCOP,Site%20Record,DSSP&params.chainsPerPage=2
  5. https://www.ebi.ac.uk/pdbe/entry/pdb/1ki4/analysis
  6. https://www.rcsb.org/pdb/explore/remediatedSequence.do?structureId=1KI4&params.chainEntityStrategyStr=all&forcePageForChain=A&params.annotationsStr=SCOP,Site%20Record,DSSP&params.chainsPerPage=2
  7. https://www.rcsb.org/structure/1KI4
  8. https://www.ebi.ac.uk/pdbe/entry/pdb/1ki4/bound/SO4#3A
  9. https://www.ebi.ac.uk/pdbe/entry/pdb/1ki4/bound/BTD
  10. https://www.rcsb.org/structure/1KI4
  11. Champness JN, Bennett MS, Wien F, Visse R, Summers WC, Herdewijn P, de Clerq E, Ostrowski T, Jarvest RL, Sanderson MR. Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands. Proteins. 1998 Aug 15;32(3):350-61. PMID:9715911
  12. https://www.who.int/fr/news-room/fact-sheets/detail/herpes-simplex-virus
  13. http://www.ipubli.inserm.fr/bitstream/handle/10608/1401/1999_5_625.pdf?sequence=4
Personal tools